ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.680,20
-0,25%
S&P 500
5.316,56
-0,09%
Dow Jones
39.829,03
-0,11%
Euro vs US Dollar
1,08419
-0,12%
Bitcoin
70.266,85
0,19%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. ContextLogic Inc (LOGC)

  7. ContextLogic Inc (LOGC) News

LOGC

ContextLogic (LOGC)

ContextLogic Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:LOGC
DatumZeitQuelleÜberschriftSymbolFirma
10/02/202322h40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LOGCContextLogic Inc
29/11/202222h07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:LOGCContextLogic Inc
21/11/202212h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LOGCContextLogic Inc
16/11/202222h05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOGCContextLogic Inc
16/11/202222h05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOGCContextLogic Inc
16/11/202222h04Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOGCContextLogic Inc
16/11/202222h04Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOGCContextLogic Inc
16/11/202222h04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:LOGCContextLogic Inc
16/11/202215h56Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:LOGCContextLogic Inc
16/11/202214h30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LOGCContextLogic Inc
16/11/202214h21Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:LOGCContextLogic Inc
14/11/202214h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LOGCContextLogic Inc
14/11/202214h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
14/11/202214h00PR Newswire (US)LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:LOGCContextLogic Inc
20/10/202214h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LOGCContextLogic Inc
18/10/202222h14Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:LOGCContextLogic Inc
18/10/202222h04Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:LOGCContextLogic Inc
13/10/202222h02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LOGCContextLogic Inc
07/10/202222h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
03/10/202222h47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:LOGCContextLogic Inc
03/10/202217h20Dow Jones NewsLogicBio Therapeutics Shares Soar on Takeover by AstraZenecaNASDAQ:LOGCContextLogic Inc
03/10/202216h50TipRanksAnalysts Offer Insights on Healthcare Companies: Clene (CLNN) and Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
03/10/202214h19TipRanksAstraZeneca to Buy LogicBio Therapeutics for $2.07 Per ShareNASDAQ:LOGCContextLogic Inc
03/10/202213h57Dow Jones NewsAstraZeneca to Buy LogicBio Therapeutics for $68 MillionNASDAQ:LOGCContextLogic Inc
03/10/202213h15Business WireAlexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineNASDAQ:LOGCContextLogic Inc
03/10/202213h10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
03/10/202213h00PR Newswire (US)Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineNASDAQ:LOGCContextLogic Inc
23/09/202223h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
21/09/202214h30PR Newswire (US)LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONENASDAQ:LOGCContextLogic Inc
20/09/202223h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
 Showing the most relevant articles for your search:NASDAQ:LOGC

Kürzlich von Ihnen besucht

AMEX
SPY
SPDR S&P 500
NASDAQ
TSLA
Tesla
NYSE
KO
Coca Cola
TG
CBK
Commerzbank
AMEX
XLF
Financial Select Sector
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
DIS
Walt Disney
FX
EURJPY
Euro vs Yen
CCOM
SILVER
SILVER
TG
D7G
Nel ASA
COIN
BTCUSD
Bitcoin
TG
LHA
Deutsche Lufthansa
NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
DBI
MDAX
MDAX
TG
BAYN
Bayer
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten